CERE DEADLINE TUESDAY: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 01 2025
0mins
Source: Globenewswire
Class Action Lawsuit Announcement: Rosen Law Firm is reminding investors who sold or held shares of Cerevel Therapeutics between October 11, 2023, and August 1, 2024, that they may be eligible for compensation through a class action lawsuit due to alleged misleading statements related to a secondary stock offering.
Details on Participation: Interested parties can join the class action by visiting the provided link or contacting the firm directly; however, no class has been certified yet, meaning individuals are not represented unless they choose counsel.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
